The table below shows AMICUS THERAPEUTICS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$634.21M
$528.29M
$399.36M
$329.23M
$305.51M
$260.89M
Cost of revenue
$72.93M
$52.94M
$37.33M
$38.60M
$34.47M
$31.04M
Gross profit
$561.28M
$475.35M
$362.03M
$290.63M
$271.05M
$229.84M
R&D
-
-
-
-
-
-
SG&A
FOLD annual revenue (10-K history)
AMICUS THERAPEUTICS, INC. reported annual revenue of $634.21M for fiscal year 2025. That is up 20.0% from $528.29M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.22M (FY 2014) to $634.21M. Figures come from the company's audited annual reports as filed with the SEC.
